Literature DB >> 7391033

Synthesis of delta 2-isopentenyl tRNA from mevalonate in cultured human fibroblasts.

J R Faust, M S Brown, J L Goldstein.   

Abstract

Human fibroblasts are shown to incorporate [3H]-mevalonolactone into 3H-labeled delta 2-isopentenyl tRNA. This incorporation was observed in cells that were incubated with compactin (ML-236B), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme. A reductase that blocks mevalonate production by cells. When incubated with low concentrations of [3H]mevalonolactone in the presence of compactin and in the absence of exogenous cholesterol, the cells incorporated small amounts of [3H]mevalonolactone into delta 2-isopentenyl tRNA and large amounts into cholesterol. In the presence of low density lipoprotein, which serves as a source of cholesterol, the incorporation of [3H]mevalonolactone into cholesterol was reduced by 90% and the incorporation into delta 2-isopentenyl tRNA was stimulated by 10-fold. Thus, cultured mammalian cells are now known to use mevalonate for synthesis of three nonsterol products, ubiquinone, dolichol, and delta 2-isopentenyl tRNA, as well as for synthesis of cholesterol.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7391033

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Defective macromolecule biosynthesis and cell-cycle progression in a mammalian cell starved for mevalonate.

Authors:  M Sinensky; J Logel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

Review 2.  The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications.

Authors:  Iain P Hargreaves; Andrew J Duncan; Simon J R Heales; John M Land
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Molecular cloning and sequence of a cholesterol-repressible enzyme related to prenyltransferase in the isoprene biosynthetic pathway.

Authors:  C F Clarke; R D Tanaka; K Svenson; M Wamsley; A M Fogelman; P A Edwards
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

4.  Localization of the gene encoding 3-hydroxy-3-methylglutaryl-coenzyme A synthase to human chromosome 5.

Authors:  S Leonard; D Arbogast; D Geyer; C Jones; M Sinensky
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

5.  Evidence for metabolic aberrations in asymptomatic persons with type 2 diabetes after initiation of simvastatin therapy.

Authors:  Manish Suneja; Daniel K Fox; Brian D Fink; Judy A Herlein; Christopher M Adams; William I Sivitz
Journal:  Transl Res       Date:  2015-01-28       Impact factor: 7.012

6.  Mapping of multiple mouse loci related to the farnesyl pyrophosphate synthetase gene.

Authors:  A Andalibi; A Diep; D Quon; T Mohandas; B A Taylor; A J Lusis
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

7.  Overexpression of farnesyl diphosphate synthase in Arabidopsis mitochondria triggers light-dependent lesion formation and alters cytokinin homeostasis.

Authors:  David Manzano; Antoni Busquets; Marta Closa; Klára Hoyerová; Hubert Schaller; Miroslav Kamínek; Montserrat Arró; Albert Ferrer
Journal:  Plant Mol Biol       Date:  2006-05       Impact factor: 4.076

8.  Neutrophils are required for the DNA synthetic response of human lymphocytes to mevalonic acid: evidence suggesting that a nonsterol product of mevalonate is involved.

Authors:  R A Larson; J Chung; A M Scanu; S Yachnin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

9.  Assessment of mitochondrial respiratory chain function in hyperphenylalaninaemia.

Authors:  N Kyprianou; E Murphy; P Lee; I Hargreaves
Journal:  J Inherit Metab Dis       Date:  2009-03-13       Impact factor: 4.982

10.  Activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase does not respond to ubiquinone uptake in cultured cells.

Authors:  W A Maltese; J R Aprille; R A Green
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.